Woman with terminal cervical cancer says New Zealand treatment ‘feels like a lottery’

A 30-year-old woman with terminal cervical cancer in New Zealand is criticizing the country's healthcare funding system, describing access to life-extending drugs as a lottery. She highlights that while some treatments are publicly funded, others like Keytruda remain prohibitively expensive for patients without specific coverage.
A woman living with terminal cervical cancer says access to life-extending treatment in New Zealand “feels like a lottery”, saying care often depends on the type of cancer and whether it qualifies for public funding.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in